ArticleCJC open2022

Reply to Yalta and Yetkin-Cardiac Sarcoidosis: Indications for Implantable Cardioverter-Defibrillator Therapy.

Stephen A Duffett et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.